Literature DB >> 30530984

A three-dimensional scaffold from decellularized human umbilical artery for bile duct reconstruction.

Konstantine Chakhunashvili, Merab Kiladze, David G Chakhunashvili, Lia Karalashvili, Zurab Kakabadze.   

Abstract

AIM: The main purpose of the study was to create in vitro bile duct equivalent out of decellularized human umbilical cord artery and use it to reconstruct common bile duct obstruction with preservation of sphincter of Oddi.
MATERIAL AND METHODS: SDS and Triton X-100 were used for decellularization of the artery. Allogeneic isolated cholangiocytes were seeded onto the inner surface of the decellularized artery. Experimental study was held and 12 domestic pigs of both sexes, weighing 25-30 kg were used. They were divided in equivalent two groups. Common bile duct obstruction model was created in all animals. Animals of the first group (n=6) received no further treatment and were under observation. Animals of the second group (n=6) underwent relaparotomy after two days of initial intervention, lesion site (2 cm) was incised and defect was reconstructed with the bile duct equivalent with the size of 2-2,5 cm. Maximum observation period was 84 days.
RESULTS: Laboratory, morphologic and radiologic investigations showed good integration with the host organism. DISCUSSION: Bile duct reconstruction is still a major of HPB surgery. This fact prompted this study to assess the efficacy of the novel method for bile duct reconstruction the experimental study by using appropriate laboratory, morphologic and radiologic investigations.
CONCLUSION: Preliminary results obtained with the described method allows us to say that bile duct equivalent created by us with decellularized human umbilical artery and cholangiocytes can be successfully used for bile duct reconstruction with inclusion of the sphincter of oddi. KEY WORDS: Bile Duct Obstruction, Bile Duct Reconstruction, Decellularization, Human Umbilical Artery.

Entities:  

Mesh:

Year:  2019        PMID: 30530984

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

1.  Efficient differentiation of vascular smooth muscle cells from Wharton's Jelly mesenchymal stromal cells using human platelet lysate: A potential cell source for small blood vessel engineering.

Authors:  Panagiotis Mallis; Aggeliki Papapanagiotou; Michalis Katsimpoulas; Alkiviadis Kostakis; Gerasimos Siasos; Eva Kassi; Catherine Stavropoulos-Giokas; Efstathios Michalopoulos
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

Review 2.  Future Perspectives in Small-Diameter Vascular Graft Engineering.

Authors:  Panagiotis Mallis; Alkiviadis Kostakis; Catherine Stavropoulos-Giokas; Efstathios Michalopoulos
Journal:  Bioengineering (Basel)       Date:  2020-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.